Facility brings advanced genetic testing capabilities to West Bengal, including prenatal, oncology, and rare disease ...

Tempus AI TEM continues to push the boundaries of precision medicine through a robust pipeline of research and development (R&D) initiatives. In June, the company introduced xM, a liquid biopsy assay ...

AAPL, ORCL, GS and PRPO are navigating growth, innovation and risk. See what Zacks analysts say about these standout names.

The global Liquid Biopsy Market is valued at USD 11.41 Billion in 2024 and is projected to reach a value of USD 30.65 Billion ...

The global DNA Sequencing Services Market is estimated to be valued at USD 1.1 billion in 2025 and is projected to reach USD 2.5 billion by 2035, registering a compound annual growth rate of 8.7% over ...